APO Research
Talk to an analyst

APO RESEARCH · REPORT

Daratumumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Daratumumab Industry Growth and Trends Forecast to 2032

23 December 202570 pages

Choose your research edition.

Industry ResearchDaratumumab Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Daratumumab Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Daratumumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daratumumab Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Daratumumab Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Daratumumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Daratumumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Daratumumab include Johnson＆Johnson. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Daratumumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Daratumumab market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Daratumumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Daratumumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Daratumumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Daratumumab Market by Company

Johnson＆Johnson

Daratumumab Segment by Type

100mg Injection

400mg Injection

Daratumumab Segment by Application

Multiple Myeloma

Follicular Lymphoma

Diffuse Large B Cell Lymphoma

Mantle Cell Lymphoma

Others

Daratumumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daratumumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daratumumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daratumumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Daratumumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Daratumumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg Injection Table 2. Major Company of 400mg Injection Table 3. Global Daratumumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Daratumumab Sales by Type (2021-2026) & (k units) Table 5. Global Daratumumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Daratumumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Daratumumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Daratumumab Price by Type (2021-2026) & (US$/unit) Table 9. Global Daratumumab Sales by Type (2027-2032) & (k units) Table 10. Global Daratumumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Daratumumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Daratumumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Daratumumab Price by Type (2027-2032) & (US$/unit) Table 14. North America Daratumumab Sales by Type (2021-2026) & (k units) Table 15. North America Daratumumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Daratumumab Sales by Type (2021-2026) & (k units) Table 17. Europe Daratumumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Daratumumab Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Daratumumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Daratumumab Sales by Type (2021-2026) & (k units) Table 21. Latin America Daratumumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Daratumumab Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Daratumumab Sales by Type (2021-2026) & (US$ Million) Table 24. Daratumumab Industry Trends Table 25. Daratumumab Industry Drivers Table 26. Daratumumab Industry Opportunities and Challenges Table 27. Daratumumab Industry Restraints Table 28. Global Daratumumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Daratumumab Revenue Market Share by Company (2021-2026) Table 30. Global Daratumumab Sales by Company (2021-2026) & (k units) Table 31. Global Daratumumab Sales Share by Company (2021-2026) Table 32. Global Daratumumab Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Daratumumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Daratumumab Major Company Production Sites and Headquarters Table 35. Global Daratumumab Company, Product Type & Application Table 36. Global Daratumumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Daratumumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Daratumumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Daratumumab Sales by Region (2021-2026) & (k units) Table 41. Global Daratumumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Daratumumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Daratumumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Daratumumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Daratumumab Sales by Region (2027-2032) & (k units) Table 46. Global Daratumumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Daratumumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Daratumumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Daratumumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Daratumumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Daratumumab Sales by Application (2021-2026) & (k units) Table 52. Global Daratumumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Daratumumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Daratumumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Daratumumab Price by Application (2021-2026) & (US$/unit) Table 56. Global Daratumumab Sales by Application (2027-2032) & (k units) Table 57. Global Daratumumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Daratumumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Daratumumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Daratumumab Price by Application (2027-2032) & (US$/unit) Table 61. North America Daratumumab Sales by Application (2021-2026) & (k units) Table 62. North America Daratumumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Daratumumab Sales by Application (2021-2026) & (k units) Table 64. Europe Daratumumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Daratumumab Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Daratumumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Daratumumab Sales by Application (2021-2026) & (k units) Table 68. Latin America Daratumumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Daratumumab Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Daratumumab Sales by Application (2021-2026) & (US$ Million) Table 71. Johnson＆Johnson Company Information Table 72. Johnson＆Johnson Business Overview Table 73. Johnson＆Johnson Daratumumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Johnson＆Johnson Daratumumab Product Portfolio Table 75. Johnson＆Johnson Recent Development Table 76. North America Daratumumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 77. North America Daratumumab Sales by Country (2021-2026) & (k units) Table 78. North America Daratumumab Sales Market Share by Country (2021-2026) Table 79. North America Daratumumab Sales Forecast by Country (2027-2032) & (k units) Table 80. North America Daratumumab Sales Market Share Forecast by Country (2027-2032) Table 81. North America Daratumumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Daratumumab Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Daratumumab Market Share by Country (2021-2026) Table 84. North America Daratumumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Daratumumab Market Share Forecast by Country (2027-2032) Table 86. Europe Daratumumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. Europe Daratumumab Sales by Country (2021-2026) & (k units) Table 88. Europe Daratumumab Sales Market Share by Country (2021-2026) Table 89. Europe Daratumumab Sales Forecast by Country (2027-2032) & (k units) Table 90. Europe Daratumumab Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Daratumumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Daratumumab Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Daratumumab Market Share by Country (2021-2026) Table 94. Europe Daratumumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Daratumumab Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Daratumumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Daratumumab Sales by Country (2021-2026) & (k units) Table 98. Asia-Pacific Daratumumab Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Daratumumab Sales Forecast by Country (2027-2032) & (k units) Table 100. Asia-Pacific Daratumumab Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Daratumumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Daratumumab Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Daratumumab Market Share by Country (2021-2026) Table 104. Asia-Pacific Daratumumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Daratumumab Market Share Forecast by Country (2027-2032) Table 106. Latin America Daratumumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Latin America Daratumumab Sales by Country (2021-2026) & (k units) Table 108. Latin America Daratumumab Sales Market Share by Country (2021-2026) Table 109. Latin America Daratumumab Sales Forecast by Country (2027-2032) & (k units) Table 110. Latin America Daratumumab Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Daratumumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Daratumumab Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Daratumumab Market Share by Country (2021-2026) Table 114. Latin America Daratumumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Daratumumab Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Daratumumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Daratumumab Sales by Country (2021-2026) & (k units) Table 118. Middle East and Africa Daratumumab Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Daratumumab Sales Forecast by Country (2027-2032) & (k units) Table 120. Middle East and Africa Daratumumab Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Daratumumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Daratumumab Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Daratumumab Market Share by Country (2021-2026) Table 124. Middle East and Africa Daratumumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Daratumumab Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Daratumumab Distributors List Table 129. Daratumumab Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Daratumumab Image Figure 2. Global Daratumumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daratumumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Daratumumab Sales (2021-2032) & (k units) Figure 5. 100mg Injection Image Figure 6. Global 100mg Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. 400mg Injection Image Figure 8. Global 400mg Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Daratumumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Daratumumab Market Share by Type 2025 VS 2032 Figure 11. North America Daratumumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Daratumumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Daratumumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Daratumumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Daratumumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Daratumumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Daratumumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Daratumumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Daratumumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Daratumumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Daratumumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Multiple Myeloma Image Figure 24. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (k units) Figure 25. Follicular Lymphoma Image Figure 26. Global Follicular Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 27. Diffuse Large B Cell Lymphoma Image Figure 28. Global Diffuse Large B Cell Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 29. Mantle Cell Lymphoma Image Figure 30. Global Mantle Cell Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Daratumumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Daratumumab Market Share by Application 2025 VS 2032 Figure 35. North America Daratumumab Sales Market Share in Volume by Application in 2025 Figure 36. North America Daratumumab Sales Market Share in Value by Application in 2025 Figure 37. Europe Daratumumab Sales Market Share in Volume by Application in 2025 Figure 38. Europe Daratumumab Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Daratumumab Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Daratumumab Sales Market Share in Value by Application in 2025 Figure 41. Latin America Daratumumab Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Daratumumab Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Daratumumab Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Daratumumab Sales Market Share in Value by Application in 2025 Figure 45. North America Daratumumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Daratumumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Daratumumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Daratumumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Daratumumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Daratumumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Daratumumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Daratumumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Daratumumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Daratumumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Daratumumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Daratumumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Daratumumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Daratumumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Daratumumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Daratumumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Daratumumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Daratumumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Daratumumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Daratumumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Daratumumab Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Daratumumab Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg Injection
  • 400mg Injection
Applications
  • Multiple Myeloma
  • Follicular Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Mantle Cell Lymphoma
  • Others
Companies covered
  • Johnson＆Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Daratumumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Daratumumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Daratumumab Market by Type
  6. 1.3.1 100mg Injection
  7. 1.3.2 400mg Injection
  8. 1.4 Global Daratumumab Market Size by Type
  9. 1.4.1 Global Daratumumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Daratumumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Daratumumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Daratumumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Daratumumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Daratumumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Daratumumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Daratumumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Daratumumab Industry Trends
  2. 2.2 Daratumumab Industry Drivers
  3. 2.3 Daratumumab Industry Opportunities and Challenges
  4. 2.4 Daratumumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Daratumumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Daratumumab Sales (2021-2026)
  3. 3.3 Global Top Players by Daratumumab Price (2021-2026)
  4. 3.4 Global Daratumumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Daratumumab Major Company Production Sites & Headquarters
  6. 3.6 Global Daratumumab Company, Product Type & Application
  7. 3.7 Global Daratumumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Daratumumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Daratumumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Daratumumab Tier 1, Tier 2, and Tier 3
4 Daratumumab Regional Status and Outlook
  1. 4.1 Global Daratumumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Daratumumab Historic Market Size by Region
  3. 4.2.1 Global Daratumumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Daratumumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Daratumumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Daratumumab Forecasted Market Size by Region
  7. 4.3.1 Global Daratumumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Daratumumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Daratumumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Daratumumab by Application
  1. 5.1 Daratumumab Market by Application
  2. 5.1.1 Multiple Myeloma
  3. 5.1.2 Follicular Lymphoma
  4. 5.1.3 Diffuse Large B Cell Lymphoma
  5. 5.1.4 Mantle Cell Lymphoma
  6. 5.1.5 Others
  7. 5.2 Global Daratumumab Market Size by Application
  8. 5.2.1 Global Daratumumab Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Daratumumab Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Daratumumab Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Daratumumab Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Daratumumab Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Daratumumab Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Daratumumab Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Daratumumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson＆Johnson
  2. 6.1.1 Johnson＆Johnson Company Information
  3. 6.1.2 Johnson＆Johnson Business Overview
  4. 6.1.3 Johnson＆Johnson Daratumumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson＆Johnson Daratumumab Product Portfolio
  6. 6.1.5 Johnson＆Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Daratumumab Sales by Country
  2. 7.1.1 North America Daratumumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Daratumumab Sales by Country (2021-2026)
  4. 7.1.3 North America Daratumumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Daratumumab Market Size by Country
  6. 7.2.1 North America Daratumumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Daratumumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Daratumumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Daratumumab Sales by Country
  2. 8.1.1 Europe Daratumumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Daratumumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Daratumumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Daratumumab Market Size by Country
  6. 8.2.1 Europe Daratumumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Daratumumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Daratumumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Daratumumab Sales by Country
  2. 9.1.1 Asia-Pacific Daratumumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Daratumumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Daratumumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Daratumumab Market Size by Country
  6. 9.2.1 Asia-Pacific Daratumumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Daratumumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Daratumumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Daratumumab Sales by Country
  2. 10.1.1 South America Daratumumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Daratumumab Sales by Country (2021-2026)
  4. 10.1.3 South America Daratumumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Daratumumab Market Size by Country
  6. 10.2.1 South America Daratumumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Daratumumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Daratumumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Daratumumab Sales by Country
  2. 11.1.1 Middle East and Africa Daratumumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Daratumumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Daratumumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Daratumumab Market Size by Country
  6. 11.2.1 Middle East and Africa Daratumumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Daratumumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Daratumumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Daratumumab Value Chain Analysis
  2. 12.1.1 Daratumumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Daratumumab Production Mode & Process
  7. 12.2 Daratumumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Daratumumab Distributors
  10. 12.2.3 Daratumumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst